Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inventiva S.A.

3.08
+0.06942.31%
Volume:11.31K
Turnover:34.99K
Market Cap:428.36M
PE:-0.97
High:3.20
Open:3.01
Low:3.01
Close:3.01
Loading ...

Singapore hotel figures slip yoy in Q1, with main drags in March; visitor arrivals steady

businesstimes
·
07 May

Statement of total voting rights and shares forming the company’s share capital as of April 11, 2025

GlobeNewswire
·
01 May

Inventiva announces the publication in Clinical Gastroenterology and Hepatology of its analysis of new biomarker signatures predictive of histological response in patients with MASH treated with lanifibranor

GlobeNewswire
·
25 Apr

Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F

GlobeNewswire
·
16 Apr

Inventiva Is Maintained at Buy by Guggenheim

Dow Jones
·
04 Apr

Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year?

Zacks
·
04 Apr

Inventiva price target lowered to $9 from $12 at Guggenheim

TIPRANKS
·
04 Apr

Inventiva Sa : Guggenheim Cuts Target Price to $9.00 From $12.00

THOMSON REUTERS
·
04 Apr

Inventiva Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Apr

Inventiva achieves milestone with Phase 3 study enrollment, says H.C. Wainwright

TIPRANKS
·
03 Apr

Inventiva Completes Enrollment in Phase 3 Study of Liver Treatment

MT Newswires Live
·
02 Apr

Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis

GlobeNewswire
·
02 Apr

Inventiva (IVA) Gets a Buy from Canaccord Genuity

TIPRANKS
·
01 Apr

Inventiva SA (IVEVF) (Q4 2024) Earnings Call Highlights: Navigating Financial Challenges and ...

GuruFocus.com
·
28 Mar

Inventiva FY24 EPS €(3.08) Down From €(2.43) YoY; Revenue €9.2 Million Down From €17.48 Million YoY

Benzinga
·
27 Mar

Inventiva reports its 2024 full year results and provides a business update

GlobeNewswire
·
27 Mar

Inventiva SA expected to post a loss of 52 cents a share - Earnings Preview

Reuters
·
24 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar

Inventiva announces the schedule of publication and presentation of its 2024 Full-Year Financial Results

GlobeNewswire
·
20 Mar

Optimistic Buy Rating for Inventiva Driven by Lanifibranor’s Promising Phase 3 Prospects and Safety Profile

TIPRANKS
·
21 Feb